Subject(s)
Whiplash Injuries/complications , Biomechanical Phenomena , Horner Syndrome/etiology , Humans , SyndromeABSTRACT
Lornoxicam is a new non-steroidal anti-inflammatory agent (NSAID) with a similar pharmacological profile to other oxicams and a potency 10 times greater than piroxicam. A multicentre, randomised, double blind, parallel group study was undertaken to compare the efficacy and tolerance of four weeks' treatment with lornoxicam (6 mg once daily, 4 mg twice daily, and 6 mg twice daily) and placebo in patients with osteoarthritis of the hip or knee. A dose related efficacy of lornoxicam was shown by the numbers of patients in each treatment group who withdrew from the trial owing to inadequate symptom relief (12/40 (30%) receiving placebo, 6/40 (15) receiving lornoxicam 6 mg daily, 4/40 (10%) receiving lornoxicam 8 mg daily, and none receiving lornoxicam 12 mg daily). This effect was confirmed by pain relief scores, which were significantly better than placebo during treatment with lornoxicam 8 mg and 12 mg daily, the effect of 12 mg daily being significantly superior to that of 8 mg daily. Similar results were obtained from functional status scores. Mean functional index (Lequesne) scores were significantly greater than placebo only at a daily dose of 12 mg lornoxicam. Lornoxicam was generally well tolerated, though some gastrointestinal side effects were seen as has been reported with other NSAIDs. Laboratory investigations showed no evidence of drug toxicity.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Hip Joint , Knee Joint , Osteoarthritis/drug therapy , Piroxicam/analogs & derivatives , Administration, Oral , Adult , Aged , Double-Blind Method , Drug Administration Schedule , Dyspepsia/chemically induced , Female , Humans , Male , Middle Aged , Pain/drug therapy , Piroxicam/administration & dosageABSTRACT
Nine patients had attacks of joint pain and sometimes swelling precipitated by certain foods or associated with allergic manifestations. All were atopic subjects--three having strong evidence of Type I (immediate) allergy and three 'urticarial arthralgia', in which attacks of severe urticaria and joint pain occurred coincidentally. Food allergy appeared to be responsible for the joint symptoms in three patients and in one it was possible to precipitate swelling of a knee due to synovitis with effusion by drinking milk a few hours beforehand, the synovial fluid having mildly inflammatory features and a relatively high eosinophil count. It seems that allergy is an occasional cause of episodic rheumatic pain or synovitis in certain atopic patients, whether or not they have an underlying arthritis. These are usually Type I hypersensitivity reactions, though it is thought that some food-allergic reactions are immune complex-mediated.
Subject(s)
Hypersensitivity, Immediate/complications , Synovitis/etiology , Adult , Animals , Female , Food Hypersensitivity/complications , Food Hypersensitivity/immunology , Humans , Male , Middle Aged , Milk/adverse effects , Synovial Fluid/immunology , Synovitis/immunologyABSTRACT
A total of 1,328 patients with osteoarthritis or rheumatoid arthritis were entered into this double-blind, parallel group study of tenoxicam and piroxicam. The patient populations were well matched. An improvement was seen in pain on moving and at night in both groups and in both indications. Stiffness was also improved by both drugs, being most marked in the rheumatoid arthritis group. The primary efficacy variable was global assessment, and this showed tenoxicam to have slightly greater effect in osteoarthritis and the reverse in rheumatoid arthritis. There were no statistically significant differences in any of these findings. There were no significant differences in tolerance ratings, although the more serious gastrointestinal events occurred in the piroxicam group.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Rheumatoid/drug therapy , Osteoarthritis/drug therapy , Piroxicam/analogs & derivatives , Piroxicam/therapeutic use , Adult , Aged , Aged, 80 and over , Double-Blind Method , Female , Humans , Male , Middle Aged , Multicenter Studies as TopicABSTRACT
Five clinical tests in common use for diagnosis of carpal tunnel syndromes have been shown to have little diagnostic value, either individually or in various combinations. No physical sign is useful in the diagnosis of this condition, which should be suspected on the basis of presenting symptoms and confirmed by electrodiagnosis using standard median nerve conduction tests.
Subject(s)
Carpal Tunnel Syndrome/diagnosis , Electrodiagnosis , Humans , Median Nerve/physiopathology , Neural ConductionSubject(s)
Polyarteritis Nodosa/pathology , Aged , Fibula/pathology , Humans , Male , Tibia/pathologyABSTRACT
An 18 year old girl concurrently developed skin lesions of morphoea (localised scleroderma) and pain and swelling of the hands and fingers. There were no dermatological or systemic signs of systemic sclerosis. The immunological features (high titred speckled antinuclear antibody, negative DNA binding, high titred positive anti-RNP and negative anti-Sm antibodies, speckled nuclear Ig fluorescence in the epidermis of the skin lesions) were consistent with mixed connective tissue disease, and it is suggested that the morphoea represented a component of this condition.
Subject(s)
Mixed Connective Tissue Disease/complications , Scleroderma, Localized/etiology , Adolescent , Female , HumansABSTRACT
Reactive arthritis following enteric infection with Salmonella schwarzengrund, a species not previously described in association with this condition, occurred in a 51-year-old man with bilateral sacro-iliitis.
